<DOC>
	<DOCNO>NCT00379847</DOCNO>
	<brief_summary>This study investigate application vasopressin antagonist treatment hyponatremia likely cause inappropriate AVP secretion . The population study include patient euvolemic hypervolemic hyponatremia .</brief_summary>
	<brief_title>An Open-Label Study YM087 ( Conivaptan ) Patients With Euvolemic Hypervolemic Hyponatremia</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Conivaptan</mesh_term>
	<criteria>Serum sodium level less equal 130mEq/L Euvolemic Hypervolemic hyponatremia Clinical evidence volume depletion dehydration Untreated severe hypothyroidism , hyperthyroidism , adrenal insufficiency Uncontrolled bradyor tachyarrhythmias require pacemaker placement treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>hyponatremia</keyword>
	<keyword>hypervolemic</keyword>
	<keyword>euvolemic</keyword>
	<keyword>treatment outcome</keyword>
	<keyword>YM087</keyword>
</DOC>